Anastrozole 1 - British Dragon

Anastrozole, marketed as Arimidex by AstraZeneca, emerged as a crucial anti-estrogen drug designed to treat hormone-responsive breast cancer in women. By inhibiting the aromatase enzyme, it significantly reduces the conversion of androgens into estrogen, effectively lowering estrogen levels. This property attracted bodybuilders and athletes seeking to control estrogenic side effects during steroid cycles, preventing gynecomastia, excessive water retention, and fat gain. Its use supports a more defined muscle appearance while maintaining a favorable anabolic environment.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Anastrozole 1 by British Dragon, consult with your doctor or healthcare professional.